Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IW-6463 in Adults with MELAS
NCT04475549Phase 2Terminated
- Sponsor
- Tisento Therapeutics
- Start
- Nov 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zagociguat in mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS), sponsored by Tisento Therapeutics. Started Nov 2020; status: terminated.
02
Drugs
zagociguat
03
Conditions
mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS)
Beyond the preview
Go deeper on NCT04475549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04475549.